April 25, 2014

Prestige Brands Holdings, whose portfolio includes Chloraseptic sore throat treatments, Clear Eyes eye care products and Compound W wart treatments, has entered into an agreement to acquire Insight Pharmaceuticals, the maker of Monistat, for $750 million in cash.

July 9, 2013

Prestige Brands Holdings announced its acquisition of Care Pharmaceuticals of Bondi Junction, New South Wales, Australia, a privately held marketer and distributor of over-the-counter healthcare brands for children and adults.

January 22, 2013

NASCAR's Dale Earnhardt Jr. has signed on as a Goody's spokesman, Prestige Brands Holdings announced.

December 21, 2012

A new product from the PediaCare line is designed to keep children hydrated when they have a cold or flu.

May 3, 2012

Prestige Brands on Thursday acknowledged that Genomma Lab has withdrawn its unsolicited acquisition proposal.

April 3, 2012

Prestige Brands Holdings on Monday announced that it has completed the purchase of the two remaining brands of the 17 brands it agreed to acquire from GlaxoSmithKline; the purchase of Debrox ear wax remover and Gly-Oxide oral rinse completes the transaction.

December 20, 2011

Prestige on Tuesday acquired 17 over-the-counter brands from GlaxoSmithKline for a total of $660 million in cash.

December 17, 2010

Prestige Brands Holdings on Thursday announced that it has entered into a definitive agreement to acquire the assets associated with the Dramamine business in the United States from McNeil Consumer Healthcare for $76 million in cash.

December 3, 2010

Prestige Brands Holdings on Thursday named Ron Lombardi its new CFO, effective Dec. 6. The position had been vacated by the retirement of Pete Anderson.

November 30, 2010

The VIA Group announced Tuesday that it has partnered with Prestige Brands Holdings to launch an integrated campaign for the pediatric over-the-counter line PediaCare.